Cancer Treatment Reviews
Volume 31, Issue 8 , Pages 640-643 , December 2005

Radical prostatectomy for early prostate cancer improves long term survival

  • Shabbir M.H. Alibhai, MD, MSc, FRPC(C)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 416 340 5125; fax: +1 416 595 5826.

References 

  1. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347:781–789
  2. Alibhai SM, Klotz LH. A systematic review of randomized trials in localized prostate cancer. Can J Urol. 2004;11:2110–2117
  3. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242–248
  4. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 1996;276:615–619
  5. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999;281:1598–1604
  6. Jani AB, Hellman S. Early prostate cancer: clinical decision-making. Lancet. 2003;361:1045–1053
  7. Scherr D, Swindle PW, Scardino PT. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology. 2003;61(Suppl 1):14–24
  8. Aus G, Abbou CC, Pacik D, et al. EAU guidelines on prostate cancer. Eur Urol. 2001;40:97–101
  9. Villers A, Pommier P, Bataillard A, et al. Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001). Br J Cancer. 2003;89(Suppl. 1):S50–S58
  10. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–1984
  11. Draisma G, Boer R, Otto SJ, et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst. 2003;95:868–878
  12. Tornblom M, Eriksson H, Franzen S, et al. Lead time associated with screening for prostate cancer. Int J Cancer. 2004;108:122–129
  13. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 1998;280:975–980
  14. Alibhai SMH, Naglie G, Nam R, Trachtenberg J, Krahn MD. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol. 2003;21:3318–3327
  15. Choo R, Klotz L, Danjoux C, et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol. 2002;167:1664–1669
  16. Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial: A randomization trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol. 1994;152:1910–1914

☆ Sources of funding: The Swedish Cancer Society.

☆☆ For correspondence: Dr. Bill-Axelson, Department of Urology, University Hospital, SE-751 85 Uppsala, Sweden. E-mail: anna.bill.axelson@akademiska.se

☆☆☆ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(05)00197-0

doi: 10.1016/j.ctrv.2005.09.008

Cancer Treatment Reviews
Volume 31, Issue 8 , Pages 640-643 , December 2005

Article Tools